I Think Investors Are Missing The Best Energy Trade For 2026
Seeking Alpha· 2025-12-16 12:30
Core Insights - The year is approaching its end, prompting evaluations of performance in various sectors [1] Group 1: Analyst Focus - Leo Nelissen specializes in analyzing major economic developments related to supply chains, infrastructure, and commodities [2] - The analysis aims to provide actionable investment ideas with a focus on dividend growth opportunities [2] Group 2: Investment Research - iREIT on Alpha offers in-depth research covering REITs, mREITs, Preferreds, BDCs, MLPs, ETFs, and other income alternatives [1]
Join AIML's Live Shareholder Update with Chairman & CEO Paul Duffy
Accessnewswire· 2025-12-16 12:30
A Look Back at Key Milestones and Successes Achieved in 2025 What's Ahead: Exciting Plans, Strategic Outlook, and Goals for 2026 Advancing the Next Phase of Commercialization TORONTO, ON / ACCESS Newswire / December 16, 2025 / AI/ML Innovations Inc. ("AIML" or the "Company") (CSE:AIML)(OTCQB:AIMLF)(FWB:42FB) is pleased to invite shareholders and stakeholders to join an upcoming Livestream Company Update, hosted by Chairman and CEO Paul Duffy. The livestream event will provide an overview of AIML's key achie ...
Nextech3D.ai Appoints Global Head of Sales
Accessnewswire· 2025-12-16 12:30
Appointment Strengthens Sales Execution as Company Focuses on Scaling Revenue and Efficiency TORONTO, ON / ACCESS Newswire / December 16, 2025 / Nextech3D.ai (CSE:NTAR)(OTCQX:NEXCF)(FSE:1SS), an AI-first technology company providing event technology, 3D modeling, and spatial computing solutions, announced today that it has appointed James McGuinness as Global Head of Sales. Mr. McGuinness will lead the Company's sales organization as Nextech focuses on expanding its commercial operations into 2026. ...
Kenorland Minerals Reports Maiden Inferred Resource of 14.5 Mt at 5.47 g/t Au for 2.55 Million Ounces at the Frotet Project, Quebec, Where It Holds a 4% NSR Royalty
TMX Newsfile· 2025-12-16 12:30
Vancouver, British Columbia--(Newsfile Corp. - December 16, 2025) - Kenorland Minerals Ltd. (TSXV: KLD) (OTCQX: KLDCF) (FSE: 3WQ0) ("Kenorland" or the "Company") is pleased to announce a maiden Inferred Mineral Resource of 14.5 Mt at 5.47 g/t for 2.55 million ounces (Moz) of gold for the Regnault gold deposit at the Frotet Project (the "Project") in northern Quebec. Kenorland holds a 4% NSR royalty (the "Frotet Royalty") across the entirety of the Project, which is 100% owned and operated by Sumitomo Metal ...
Seabridge Gold Plans to Spin-Out 11.0 Million Ounce Courageous Lake Gold Project
TMX Newsfile· 2025-12-16 12:30
Toronto, Ontario--(Newsfile Corp. - December 16, 2025) - Seabridge Gold Inc. (TSX: SEA) (NYSE: SA) ("Seabridge" or the "Company") announces today its intention to spin-out its wholly owned subsidiary, Seabridge Gold (NWT) Inc. (to be renamed "Valor Gold") which owns 100% of the Courageous Lake Gold Project ("Courageous Lake" or the "Project"), located in Canada's Northwest Territories. Following the spin-out, Valor Gold will be focused on advancing the Project through exploration, engineering and permittin ...
Palvella Therapeutics Granted FDA Fast Track Designation for QTORIN™ 3.9% Rapamycin Anhydrous Gel (QTORIN™ rapamycin) for the Treatment of Angiokeratomas
Globenewswire· 2025-12-16 12:30
Core Insights - The FDA has granted Fast Track designation to QTORIN™ rapamycin for the treatment of angiokeratomas, highlighting its potential to address a significant unmet medical need [1][2][3] - Palvella Therapeutics plans to initiate a Phase 2 trial for QTORIN™ rapamycin in the second half of 2026, following discussions with the FDA [1][4] Company Overview - Palvella Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing therapies for serious, rare skin diseases without FDA-approved treatments [5] - The company is developing a pipeline of product candidates based on its QTORIN™ platform, with QTORIN™ rapamycin as the lead candidate targeting microcystic lymphatic malformations, cutaneous venous malformations, and clinically significant angiokeratomas [5] Industry Context - Angiokeratomas are chronic skin lesions with no FDA-approved therapies, affecting an estimated 50,000 diagnosed patients in the U.S. [1][2] - The FDA's Fast Track program aims to expedite the development and review of drugs for serious conditions, facilitating earlier access for patients [3]
Integer Holdings Corporation Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights – ITGR
Businesswire· 2025-12-16 12:30
LOS ANGELES--(BUSINESS WIRE)--Integer Holdings Corporation Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights – ITGR. ...
Silver North Announces Increase in Flow Through Share Private Placement
Thenewswire· 2025-12-16 12:30
Core Viewpoint - Silver North Resources Ltd. has announced an increase in its non-brokered private placement, aiming for gross proceeds of up to $2,250,500 from the sale of 6,430,000 flow-through shares at a price of $0.35 per share [1][2]. Group 1: Offering Details - The Offering is fully subscribed and will close shortly [2]. - The proceeds from the sale of flow-through shares will be used to incur eligible Canadian exploration expenses related to the Company's Yukon projects, with a deadline for incurring these expenses set for December 31, 2026 [3]. Group 2: Company Overview - Silver North's primary assets include the 100% owned Haldane Silver Project, the Tim Silver Project (under option to Coeur Mining, Inc.), and the GDR project, all located in favorable jurisdictions for silver mining [4]. - The Company is listed on the TSX Venture Exchange under the symbol "SNAG" and also trades on the OTCQB market in the United States under the symbol "TARSF" [5].
Zimmer Biomet, OneStep Collaborate to Provide Enhanced Mobility Data to Patients and Surgeons to Help Improve Joint Procedure Recovery
Prnewswire· 2025-12-16 12:30
®OneStep's Clinically Validated Mobility Intelligence Technology to Integrate into Zimmer Biomet's mymobility Care Management Platform to Further Enhance Recovery Monitoring WARSAW, Ind., Dec. 16, 2025 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, and OneStep, the FDA-listed digital fall prevention and mobility intelligence platform, today announced an exclusive collaboration agreement aimed at delivering the orthopedic industry's most comprehensive se ...
DeFi Technologies' Subsidiary Valour Approved to List Valour Solana (VSOL) ETP on Brazil's B3 Exchange
Prnewswire· 2025-12-16 12:30
Core Insights - DeFi Technologies' subsidiary Valour has received approval from B3 to list Valour Solana (VSOL), expanding its digital asset ETP offerings in Brazil [1][9] - VSOL is set to begin trading on December 17, 2025, alongside other Valour ETPs, providing Brazilian investors with BRL-denominated exposure to Solana [2][9] - This approval marks a significant step in Valour's international expansion strategy, establishing a foothold in Brazil as its first major market outside Europe [5][9] Expansion of ETP Platform - Valour currently offers around 100 digital asset ETPs across Europe and operates the largest selection of digital asset ETPs globally [4] - The addition of VSOL positions Solana alongside Bitcoin, Ethereum, XRP, and Sui, enhancing the diversified digital asset offerings on B3 [3][9] - Valour aims to provide institutional-grade access to digital assets through regulated, exchange-traded products, catering to the growing demand in Brazil [7][9] Market Context - Brazil is recognized as Latin America's largest financial market, with a unified regulatory and capital-markets infrastructure, and is the region's largest crypto economy [6] - The introduction of regulated ETPs like VSOL is intended to offer Brazilian institutions and qualified investors transparent access to digital assets [7][9] - The Brazilian market is characterized by increasing participation from both retail and institutional investors in the crypto space [6]